Maureen

I, Maureen George, residing in United States, a member of the Medical and Chemicals Technical Options Committee declare as follows.

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am an Associate Professor at Columbia University School of Nursing. My responsibilities include leading an independent program of research in asthma, COPD and ILD in vulnerable populations, teaching in the PhD and master’s nursing programs, and meeting other service requirements.
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines.  I understand that this written agreement is a condition of my service.
4. My interests , and those of my personal partner and dependents, include the following (if answer is yes, describe briefly)
   • Proprietary interests: I do not have proprietary interest in a substance, technology or process to be considered by TEAP or any of its TOCs or temporary subsidiary bodies (e.g. task forces).
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: Honoraria received as a consultant to/speaker for Astra-Zeneca, Genentech Sanofi Genzyme/Regeneron, and Teva.
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: Effort (salary) support on NIH grants studying behavioral interventions in asthma, COPD and ILD.
   • Other interests: None.
5. The source of funding for my participation in the work of the Medical and Chemicals Technical Options Committee is Columbia University. By “funding” I mean I will be paid my regular annual salary for the time spent on this committee work and will receive partial reimbursement for committee travel expenses. I will personally cover all other expenses relating to my work on behalf of the committee.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines. 
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the Medical and Chemicals Technical Options Committee.
9. I understand that this DOI will expire no later than one year after I have signed it.

Name: Maureen George
Date: 19th April 2021